首页> 外国专利> METHODS FOR DIAGNOSIS OR DETECT colorectal adenomas ADVANCED AND NEOPLASMS COLORECTAL IN A SUBJECT HUMAN, BIOMARKERS OR biosignatures FOR colorectal adenomas ADVANCED AND NEOPLASMS COLORECTAL, KITS FOR DIAGNOSTIC colorectal adenomas ADVANCED AND USE adenomas RISK DIAGNOSIS colorectal ADVANCED AND / OR NEOPLASM COLORECTAL AND USE OF THE KIT

METHODS FOR DIAGNOSIS OR DETECT colorectal adenomas ADVANCED AND NEOPLASMS COLORECTAL IN A SUBJECT HUMAN, BIOMARKERS OR biosignatures FOR colorectal adenomas ADVANCED AND NEOPLASMS COLORECTAL, KITS FOR DIAGNOSTIC colorectal adenomas ADVANCED AND USE adenomas RISK DIAGNOSIS colorectal ADVANCED AND / OR NEOPLASM COLORECTAL AND USE OF THE KIT

机译:诊断或检测对象的大肠腺瘤进展和坏死性结肠直肠癌的方法,用于大肠腺瘤和坏死性结肠直肠癌的生物标志物或生物印记,用于诊断性大肠腺瘤的已发展结直肠腺瘤和/或腺瘤风险的诊断/检测

摘要

“Methods for diagnosing or detecting advanced colorectal adenomas and colorectal neoplasia in a human subject, biomarkers or biosignatures for advanced colorectal adenomas and colorectal neoplasia, kits for diagnosing advanced colorectal adenomas or colorectal adenomas / risk The present invention relates generally to the field of colorectal cancer detection, and more particularly, to plasma microrna for the detection of early colorectal cancer. Specifically, the present invention includes methods, kits and biomarkers for diagnosing or detecting colorectal neoplasia in a human subject comprising the steps of: a method for diagnosing or detecting colorectal neoplasia in a human subject comprising the steps of: obtaining one or more samples of the subject suspected of suffering from colorectal neoplasia; measuring an overall expression level or pattern of one or more microwaves obtained from one or more biological samples from the subject; and comparing the global expression pattern of one or more microrna of the biological sample of the subject suspected of having colorectal neoplasia with the global expression pattern of one or more microrna of a biological sample of a normal subject, where the normal subject is a healthy subject who does not suffer from colorectal neoplasia, where overexpression of a combination of mir19a and mir19b, or mir19a and mir19b and mir15b is indicative of colorectal cancer.
机译:“用于在人类受试者中诊断或检测晚期结肠直肠腺瘤和结肠直肠瘤的方法,用于晚期结肠直肠腺瘤和结肠直肠瘤的生物标记或生物印记,用于诊断晚期结肠直肠腺瘤或结肠直肠腺瘤/风险的试剂盒本发明总体上涉及结肠直肠癌领域血浆微核糖核酸检测,尤其是用于早期大肠癌检测的血浆微核糖核酸。具体地,本发明包括用于诊断或检测人类受试者的结直肠瘤形成的方法,试剂盒和生物标记物,其包括以下步骤:用于诊断或检测人类受试者的结直肠瘤形成的方法,包括以下步骤:获得一种或多种人结肠直肠肿瘤的方法。怀疑患有大肠肿瘤的受试者;测量从受试者的一种或多种生物样品获得的一种或多种微波的总体表达水平或模式;并将疑似患有结直肠肿瘤的受试者的一种或多种微生物的整体表达模式与正常受试者的生物样品的一种或多种微米的整体表达模式进行比较,其中所述正常受试者为健康受试者不患有结直肠肿瘤的患者,其中mir19a和mir19b或mir19a和mir19b和mir15b的组合的过表达表明大肠癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号